PIN15 COST-EFFECTIVENESS ANALYSIS OF 1-YEAR PEGINTERFERON ALFA-2A VERSUS 3 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73295-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)73295-8/fulltext
Title : PIN15 COST-EFFECTIVENESS ANALYSIS OF 1-YEAR PEGINTERFERON ALFA-2A VERSUS 3 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73295-8&doi=10.1016/S1098-3015(11)73295-8
First page : A549
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 1453
Categories :
Tags :
Regions :
ViH Article Tags :